Join to View Full Profile
200 1st StRochester, MN 55905
Phone+1 507-284-2511
Dr. Suh is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Stanford Health Care-Sponsored Stanford UniversityFellowship, Infectious Disease, 2008 - 2012
Temple University HospitalResidency, Internal Medicine, 2004 - 2007
Lewis Katz School of Medicine at Temple UniversityClass of 2004
Certifications & Licensure
MN State Medical License 2018 - 2026
WI State Medical License 2022 - 2025
CA State Medical License 2008 - 2019
PA State Medical License 2004 - 2008
American Board of Internal Medicine Infectious Disease
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2011-2013
Clinical Trials
- Triclosan, Triclocarban, and the Microbiota Start of enrollment: 2011 Jul 01
- Bacteriophage Therapy in Patients With Prosthetic Joint Infections Start of enrollment: 2022 Oct 01
- Gram-Negative Bloodstream Infection Oral Antibiotic Therapy Trial Start of enrollment: 2024 Feb 22
Roles: Contact, Principal Investigator
Publications & Presentations
PubMed
- Here's to a Future Beyond Reconstructive Surgery for Pelvic Osteomyelitis.Said El Zein, Matthew M Melin, Gina A Suh, N V Tran, Peter S Rose
Clinical Infectious Diseases. 2025-09-16 - First Use of Phage Therapy in Canada for the Treatment of a Life-Threatening, Multidrug-ResistantPeriprosthetic Joint Infection.Melissa T Cammuso, Bradley W M Cook, D William Cameron, Stephen Ryan, Marielou Tamayo
Viruses. 2025-08-14 - 9 citationsBacteriophage therapy for multidrug-resistant infections: current technologies and therapeutic approaches.Minyoung Kevin Kim, Gina A Suh, Grace D Cullen, Saumel Perez Rodriguez, Tejas Dharmaraj
The Journal of Clinical Investigation. 2025-03-03
Press Mentions
91 Days Later: Biomx’s Phage Fights off Diabetic Bone Infection in Phase IIMarch 31st, 2025- Inaugural Stephen Lerner, M.D., Lecture Scheduled for Dec. 6November 18th, 2022
- Do's and Don'ts of (Almost) Post-Pandemic TravelJune 15th, 2021
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
